Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUN-131 TDS for Chalazion
NCT02338648Phase 2Completed
- Sponsor
- Senju Pharmaceutical Co., Ltd.
- Start
- Oct 2014
- Primary completion
- Jan 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of triamcinolone acetonide in chalazion, sponsored by Senju Pharmaceutical Co., Ltd.. Started Oct 2014; status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
chalazion
Beyond the preview
Go deeper on NCT02338648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02338648.